This Administrative Core will provide the coordination and oversight required for the success of the POl. This will require prompt and efficient appointment of personnel and purchase of supplies and equipment, all of which is handled by this Core. In addition, monthly meetings of all POl investigators to monitor progress and the annual meeting of the Advisory Board to provide a critical evaluation of progress and future directions must be organized. The Advisory Board meetings require considerable planning and coordination to assure that all advisors and POl members can attend and that the logistics are in place for a successful meeting. The assembly and submission of the progress reports and non-competing renewals of the POl will also be the responsibility of this Core. As we encounter new opportunities or new problems in the directions of the POl, we plan to invite scientists with needed expertise to visit the Waggoner Center. We have not requested funds for these visits as we hope to fund their visits through ongoing seminar programs, but coordination of these visits will be handled by this Core.

National Institute of Health (NIH)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Austin
United States
Zip Code
Most, D; Ferguson, L; Blednov, Y et al. (2015) The synaptoneurosome transcriptome: a model for profiling the emolecular effects of alcohol. Pharmacogenomics J 15:177-88
Cornelison, Garrett L; Mihic, S John (2014) Contaminating levels of zinc found in commonly-used labware and buffers affect glycine receptor currents. Brain Res Bull 100:1-5
Mayfield, Jody; Ferguson, Laura; Harris, R Adron (2013) Neuroimmune signaling: a key component of alcohol abuse. Curr Opin Neurobiol 23:513-20
Kirson, Dean; Cornelison, Garrett L; Philpo, Ashley E et al. (2013) Physiological concentrations of zinc reduce taurine-activated GlyR responses to drugs of abuse. Neuropharmacology 75:286-94